德國(guó)BIOLOG專注于核苷酸相關(guān)產(chǎn)品，產(chǎn)品主要包括環(huán)核苷酸、Epac抑制劑、核堿基、核苷、核苷2' ，3' ＆5'-單磷酸、核苷5'-二磷酸、核苷5'-三磷酸、親和色譜介質(zhì)、熒光核苷酸、c-diGMP，c-diAMP，cGAMP類似物、環(huán)狀寡核苷酸、NAD，ADPR和核糖類似物、二核苷多磷酸鹽、烷基磷酸三酯等。
德國(guó)BIOLOG已通過ISO 9001:2015檢測(cè)。產(chǎn)品純度一般≥95% (HPLC)。
相關(guān)產(chǎn)品
M 034 8- (4- Methoxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pMeOPT-2'-O-Me-cAMP ) 612513-16-3
M 036 2'- O- Methylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cGMP ) [949909-73-3]
M 037 2'- / 3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-AMP ) 85287-53-2
M 038 N6- Methyladenosine- 5'- O- monophosphate ( 6-Me-5'-AMP ) 81921-35-9
M 039 N6- Methyladenosine- 5'- O- triphosphate ( 6-Me-ATP ) 3130-39-0
M 040 2'- / 3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-ADP ) 151481-85-5
M 041 2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-GDP ) 148821-02-7
M 042 2'-/ 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-GMP ) 85287-54-3
M 043 6- Methylmercaptopurine riboside 342-69-8
M 044 6- Mercaptopurine riboside 574-25-4
M 045 2'- O- Methylguanosine 2140-71-8
M 046 8- Mercaptoguanosine 26001-38-7
M 047 2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- [(β, γ)- imidotriphosphate] ( MANT-GppNHp ) 148821-01-6
M 050 2'- O- Methyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cAMP ) 40269-29-2
M 053 2'- O- (N'- Methylanthraniloyl)cytidine- 3', 5'- cyclic monophosphate ( MANT-cCMP ) pending
M 054 2'- O- Methyladenosine ( 2'-O-Me-Ado ) 2140-79-6
M 061 8- (4- Methoxyphenylthio)adenine ( 8-pMeOPT-Ade ) 696574-56-8
M 062 8- (4- Methoxyphenylthio)adenosine ( 8-pMeOPT-Ado ) 696574-56-8
M 063 8- Methylamino- cyclic inosine diphosphate ribose ( 8-MA-N1-cIDPR ) pending
M 064 8- Methylthio- cyclic inosine diphosphate ribose ( 8-MeS-N1-cIDPR ) pending
M 072 2'- / 3'- O- (N'- Methylanthraniloyl)inosine- 5'- O- monophosphate ( MANT-5'-IMP ) pending
M 074 N6- (1- Methylbutyl)adenosine- 5'- O- (3-thiotriphosphate) ( 6-(1-MeBu)-ATP-γ-S ) pending
M 080 8- (4- Mercaptobutylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-MBT-cAMP ) 1033893-75-2
M 084 N6- Methoxy- 2, 6- diaminopurine- 2'- deoxyriboside- 5'- O- triphosphate ( dKTP ) 189278-08-8
M 085 2'- O- Methyl- cyclic diadenosine monophosphate ( 2'-O-Me-c-diAMP / c-(2'-O-Me-ApAp) ) pending
M 086 2'- O- Methyl- cyclic diguanosine monophosphate ( 2'-O-Me-c-diGMP / c-(2'-O-Me-GpGp) ) 849214-01-3
M 092 4- Methylphenyl- 2, 4, 6- trimethylphenylsulfone ( ESI-05 ) 5148-64-5
M 102 2'- O- (N'- Methylanthraniloyl)- cyclic diguanosine monophosphate ( MANT-c-diGMP ) pending
M 103 2'- O- (N'- Methylanthraniloyl)- cyclic diadenosine monophosphate ( MANT-c-diAMP ) pending
M 112 2'- O- Methylcytidine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-2'-O-Me-CTP-α-S ) 143029-01-0
M 113 2'- O- Methylguanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-2'-O-Me-GTP-α-S ) 143029-02-1
M 121 2'- O- Methylcytidine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-2'-O-Me-CTP-α-S ) 143028-95-9
M 122 2'- O- Methylguanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-2'-O-Me-GTP-α-S ) 143028-96-0
M 130 P1- (5'- [2'- / 3'- O- (N'- Methylanthraniloyl)adenosyl])- P4- (5'- adenosyl)- tetraphosphate ( MANT-Ap4A / MANT-AppppA ) 877666-36-9
M 131 P1- (5'- [2'- / 3'- O- (N'- Methylanthraniloyl)adenosyl])- P4- (5'- [2'- / 3'- O- (N'- methylanthraniloyl)adenosyl])- tetraphosphate ( MANT-Ap4-MANT-A / MANT-Apppp-MANT-A ) pending
N 001 8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-NBD-cGMP ) 115993-88-9
N 002 8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-NBD-cAMP ) 221905-51-7
N 003 8- Nitroguanine ( 8-NO2-Gua ) 168701-80-2
N 004 8- Nitroguanosine ( 8-NO2-Guo ) 337536-53-5
N 006 β- Nicotinamide- 8- bromohypoxanthine dinucleotide ( 8-Br-NHD+ ) 477782-33-5
N 007 4- Nitrobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 4-NO2-cBIMP ) 127634-21-3
N 010 β- Nicotinamide- 1, N6- ethenoadenine dinucleotide ( ε-NAD+ ) 38806-38-1
N 011 8- Nitroguanosine- 3', 5'- cyclic monophosphate ( 8-NO2-cGMP ) pending
N 012 β- Nicotinamide- N6- (2- (6- [biotinyl]aminohexanoyl)aminoethyl)adenine dinucleotide ( 6-Biotin-17-NAD+ ) pending
N 013 β- Nicotinamide- N6- (2- aminoethyl)adenine dinucleotide ( 6-AE-NAD+ ) 59587-50-7
N 016 β- Nicotinamide- 8- bromo- 7- deazaadenine dinucleotide ( 8-Br-7-CH-NAD+ ) 189876-09-3
N 017 β- Nicotinamide- 8- bromoadenine dinucleotide ( 8-Br-NAD+ ) 52977-37-4
N 018 β- Nicotinic acid adenine dinucleotide phosphate ( β-NAADP+ ) 5502-96-5
N 019 β- Nicotinic acid- 1, N6- ethenoadenine dinucleotide phosphate ( ε-NAADP+ ) 217313-72-9
N 023 β- Nicotinamide- N6- (2- (6- [fluoresceinyl]aminohexanoyl)aminoethyl)adenine dinucleotide ( 6-Fluo-10-NAD+ ) pending
N 024 β- Nicotinamide- 1, N6- ethenoadenine dinucleotide phosphate ( ε-NADP+ ) 104809-28-1
N 025 β- Nicotinamide- 8- methylaminoadenine dinucleotide ( 8-MA-NAD+ ) 1262426-04-9
N 033 β- Nicotinamide- 8- (4- chlorophenylthio)adenine dinucleotide ( 8-pCPT-NAD+ ) pending
N 036 β- Nicotinamide- 8- butylthioadenine dinucleotide ( 8-BuT-NAD+ ) pending
N 037 β- Nicotinamide- 8- cyclopentylthioadenine dinucleotide ( 8-cPeT-NAD+ ) pending
N 038 β- Nicotinamide- 8- ethylthioadenine dinucleotide ( 8-ET-NAD+ ) pending
N 050 β- Nicotinamide adenine dinucleotide- 2', 3'- cyclic monophosphate ( NADcP+ / 2',3'-cyclic NADP+ ) 100929-77-9
P 001 β- Phenyl- 1, N2- ethenoguanosine- 3', 5'- cyclic monophosphate ( PET-cGMP ) 78080-27-0
P 002 8- Piperidinoadenosine- 3', 5'- cyclic monophosphate ( 8-PIP-cAMP ) 31357-06-9
P 003 8- Bromo- β- phenyl- 1, N2- ethenoguanosine- 3', 5'-cyclic monophosphate ( 8-Br-PET-cGMP ) 144510-04-3
P 004 8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-PIP-cAMPS ) 156816-36-3
P 005 8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-PIP-cAMPS ) 156816-35-2
P 006 N6- Phenyladenosine- 3', 5'- cyclic monophosphate ( 6-Phe-cAMP ) 34051-30-4
P 007 8- Bromo- ?- phenyl- 1, N2- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-PET-cGMPS ) 172806-20-1
P 008 8- Bromo- β -phenyl- 1, N2- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-PET-cGMPS ) 172806-21-2
P 009 Purine riboside- 5'- O- triphosphate ( PuTP ) 23197-96-8
P 011 Purine riboside- 5'- O- monophosphate ( 5'-PuMP ) 13484-60-1
P 012 N6-(2- Phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-ATP ) 181705-62-4
P 013 N6-(2- Phenylethyl)adenosine- 5'- O- diphosphate ( 6-PhEt-ADP ) 681175-76-8
P 014 N6- Phenyladenosine- 5'- O- diphosphate ( 6-Phe-ADP ) 105701-92-6
P 015 N6- Phenyladenosine- 5'- O- triphosphate ( 6-Phe-ATP ) 105740-47-4
P 016 Purine riboside ( PuR ) / Nebularine 550-33-4
P 018 N6- Phenyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Phe-cAMPS ) 169335-92-6
P 019 8- [ Pharos-575]- adenosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-cAMP ) pending
P 020 8- [ Pharos-575]- guanosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-cGMP ) pending
P 021 8- [ Pharos-575]- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-2'-O-Me-cAMP ) pending
P 023 5'- Phosphoguanylyl- (3' ?> 5')- guanosine ( pGpG ) 33008-99-0
P 024 8- [ Pharos-450]- adenosine- 3', 5'- cyclic monophosphate ( 8-[φ-450]-cAMP ) pending
P 025 8- [ Pharos-450]- guanosine- 3', 5'- cyclic monophosphate ( 8-[φ-450]-cGMP ) pending
P 026 N6- (2- Phenylethyl)adenosine- 5'- O- (3- thiotriphosphate) ( 6-PhEt-ATP-γ-S ) 944834-43-9
P 029 N6- Phenyladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-6-Phe-cAMPS ), sodium salt 169335-91-5
P 030 Phosphate tris(acetoxymethyl)ester ( PO4-AM3 ) 148334-61-6
P 031 8- Phenylthioadenine ( 8-PT-Ade ) 908117-27-1
P 032 8- Phenylthioadenosine ( 8-PT-Ado ) 908117-27-1
P 033 5'- Phosphoadenylyl- (3' ?> 5')- adenosine ( pApA ) 3593-47-3
P 034 8- Phenylethylthio- cyclic inosine diphosphate ribose ( 8-PhEtT-N1-cIDPR ) pending
P 044 N6- Phenyladenosine- 5'- O- (3- thiotriphosphate) ( 6-Phe-ATP-γ-S ) pending
R 001 1- β- D- Ribofuranosyl- 1, 2, 4- triazole- 3- carboxamide- 5'- O- triphosphate ( Ribavirin-5'-O-triphosphate / RTP ) 63142-71-2
S 001 Determination and quantification of c-diAMP and c-diGMP in biological systems none
T 002 Thymidine- 5'- O- (1- thiotriphosphate), Rp-isomer ( Rp-TTP-α-S ) / 2'- Deoxythymidine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dTTP-α-S ) 83199-35-3
T 003 Thymidine- 5'- O- (1- thiotriphosphate), Sp-isomer ( Sp-TTP-α-S ) / 2'- Deoxythymidine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dTTP-α-S ) 83199-32-0
T 004 Thymidine- 5'- O- monophosphorothioate ( 5'-TMPS ) 15548-51-3
T 005 Thymidine- 3', 5'- cyclic monophosphate ( cTMP ) 76567-90-3
T 006 2', 3', 5'- Triacetylinosine 3181-38-2
T 007 2', 3', 5'- Tri- O- benzoylguanosine ( 2',3',5'-TBnz-Guo ) 66048-53-1
T 008 Thymidine- 5'- O- (α, β- methylene)diphosphate ( TMP-CP ) 55065-40-2
T 009 N2, N2, 7- Trimethylguanosine ( m2,2,7G / TMG ) 40027-70-1
T 012 Thymidine- 3', 5'- O- bisphosphate ( pTp ) / 2'- Deoxythymidine- 3', 5'- O- bisphosphate 2863-04-9
T 014 6- Thioguanosine- 5'- O- monophosphate ( 6-T-5'-GMP ) 74686-78-5
T 015 6- Thioguanosine- 5'- O- diphosphate ( 6-T-GDP ) 16541-19-8
T 016 6- Thioguanosine- 5'- O- triphosphate ( 6-T-GTP ) 17670-19-8
T 017 2'- O- (6- [ Tetramethylrhodaminyl]aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-TAMRA-AHC-cGMP ) pending
T 018 2'- O- (2- [ Tetramethylrhodaminyl]aminoethylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-TAMRA-AEC-cGMP ) pending
T 020 2'- / 3'- O- (6- [ Tetramethylrhodaminyl]aminoethylcarbamoyl)guanosine- 5'- O- monophosphate ( 2'-/3'-TAMRA-AEC-5'-GMP ) pending
T 025 2', 3'- O- (2, 4, 6- Trinitrophenyl)adenosine- 5'- O- triphosphate ( TNP-ATP ) 120360-48-7
T 026 2', 3'- O- (2, 4, 6- Trinitrophenyl)guanosine- 5'- O- triphosphate ( TNP-GTP ) 612837-26-0
T 037 2- Trifluoromethyl- 1- β- D- ribofuranosylbenzimidazole- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-CF3-cBIMPS ) pending
U 001 Uridine- 3', 5'- cyclic monophosphate ( cUMP ) 56632-58-7
U 002 Uridine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-UTP-α-S ) 71214-30-7
U 003 Uridine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-UTP-α-S ) 71214-29-4
U 004 Uridine- 2', 3'- cyclic monophosphate ( 2',3'-cUMP ) 15718-50-0
U 006 Uridine- 5'- O- monophosphorothioate ( 5'-UMPS ) 15548-52-4
U 008 P1- (5'- Adenosyl)- P4- (5'- uridyl)- tetraphosphate / Uridine adenosine tetraphosphate ( Ap4U / Up4A ) 10527-48-7
U 009 Uridine- 5'- O- (α, β- methylene)diphosphate ( UMP-CP ) 732921-73-2
U 010 Uridine- 5'- O- (3- thiotriphosphate) ( UTP-γ-S ) 79049-97-1
U 011 Uridine- 5'- O- (2- thiodiphosphate) ( UDP-β-S / UDP-beta-S ) 221010-51-1
U 014 Uridine- 5'- O- triphosphoro- γ- 1- (5- sulfonic acid)naphthylamidate ( UTP-γ-AmNS / (γ-AmNS)-UTP ) 72218-69-0
U 015 Uridine- 2'- O- monophosphate ( 2'-UMP ) 131-83-9
U 016 Uridine- 3'- O- monophosphate ( 3'-UMP ) 84-53-7
U 017 Uridine- 5'- O- diphosphate, immobilized on a polymeric matrix ( UDP-Gel / UDP-Agarose ) none
W 001 PKG inhibitor peptide W45 pending
X 001 Xanthosine- 3', 5'- cyclic monophosphate ( cXMP ) 31319-70-7
C 130 Cyclic diguanosine monophosphorodithioate, Rp- / Sp- isomers ( Rp,Sp-c-diGMPSS ) 1259875-47-2
C 132 2'- / 3'- O- (5- Chloroanthraniloyl)inosine- 5'- O- triphosphate ( Cl-ANT-ITP ) 1350521-48-0
C 136 4- Cyclopentyl- 2- (2, 5- dimethylbenzylsulfanyl)- 6- oxo- 1, 6- dihydropyrimidine- 5- carbonitrile ( HJC0197 ) 1383539-73-8
C 145 Cyclic (adenosine monophosphate- 8- bromoguanosine monophosphate) ( c-(Ap-8-Br-Gp) / 8-Br-cGAMP ) pending
C 146 8- Chloro- cyclic diadenosine monophosphate ( 8-Cl-c-diAMP ) pending
C 149 Cyclic (adenosine monophosphate- 8- (2- aminoethylthio)guanosine monophosphate) ( c-(Ap-8-AET-Gp) / 8-AET-cGAMP ) pending
C 157 Cyclic (adenosine monophosphate- 8- (2- [biotinyl]aminoethylthio)guanosine monophosphate) ( c-(Ap-8-[Biotin]-AET-Gp) / 8-[Biotin]-AET-cGAMP ) pending
C 159 Cyclic (adenosine monophosphate- 8- (2- [fluoresceinyl]aminoethylthio)guanosine monophosphate) ( c-(Ap-8-Fluo-AET-Gp) / 8-Fluo-AET-cGAMP ) pending
C 161 Cyclic (guanosine- (2' ?> 5')- monophosphate- adenosine- (3' ?> 5')- monophosphate) ( c[G(2',5')pA(3',5')p] / cGAMP(2'-5') / 2'3'-cGAMP / 2',5'-3',5'-cGAMP ) 1441190-66-4
C 162 Cyclic diguanosine- (2' ?> 5')- monophosphate / cyclic bis (2' ?> 5') diguanylic acid ( c[G(2',5')pG(2',5')p] / 2',5'-2',5'-c-diGMP / c-diGMP(2'-5') ) 389873-75-0
C 166 Cyclic (adenosine monophosphate- 8- (2- aminoethylthio)guanosine monophosphate), immobilized on agarose gel ( c-(Ap-8-AET-Gp)-Agarose ) none
C 172 Cyclic (8- bromoguanosine- (2' ?> 5')- monophosphate- adenosine- (3' ?> 5')- monophosphate) ( c[8-Br-G(2',5')pA(3',5')p] ) pending
C 175 Cyclic (8- (2- aminoethylthio)guanosine- (2' ?> 5')- monophosphate- adenosine- (3' ?> 5')- monophosphate) ( c[8-AET-G(2',5')pA(3',5')p] ) pending
C 176 Cyclic (8- (2- [biotinyl]aminoethylthio)- guanosine- (2' ?> 5')- monophosphate- adenosine- (3' ?> 5')- monophosphate) ( c[8-[Biotin]-AET-G(2',5')pA(3',5')p] ) pending
C 178 Cyclic (8- (2- [fluoresceinyl]aminoethylthio)- guanosine- (2' ?> 5')- monophosphate- adenosine- (3' ?> 5')- monophosphate) ( c[8-Fluo-AET-G(2',5')pA(3',5')p] / 8-Fluo-AET-cGAMP(2'-5') ) pending
D 001 5, 6- Dimethylbenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DM-cBIMP ) 142754-31-2
D 002 2', 3'- Dideoxyadenosine ( ddA ) 4097-22-7
D 003 2'- Deoxyadenosine- 5'- O- monophosphorothioate ( 5'-dAMPS ) 64145-26-2
D 004 2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-dADP-α-S ) 120496-69-7
D 005 2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-dADP-α-S ) 120496-69-7
D 006 2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dATP-α-S ) 87358-15-4
D 007 2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dATP-α-S ) 80875-87-2
D 008 N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( DB-cAMP-AM ) 159910-48-2
D 009 N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), high purity grade 16980-89-5
D 009 E N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), economy grade 16980-89-5
D 010 N2, 2'- O- Dibutyrylguanosine- 3', 5'- cyclic monophosphate ( DB-cGMP ) 51116-00-8
D 011 5, 6- Dichlorobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DCl-cBIMP ) 129693-10-3
D 012 5, 6- Dichloro- 1- ?- D- ribofuranosyl benzimidazole ( DRB ) 53-85-0
D 013 5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Rp- isomer ( Rp-5,6-DCl-cBIMPS ) 120912-55-2
D 014 5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Sp- isomer ( Sp-5,6-DCl-cBIMPS ) 120912-54-1
D 015 2'- Deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-dcAMP ) 93839-95-3
D 016 N2, N2- Dimethylguanosine ( m22Guo ) 2140-67-2
D 018 2', 3'- Dideoxyadenosine- 5'- O- triphosphate ( ddATP ) 132619-65-9
D 019 2', 3'- Dideoxyguanosine- 5'- O- triphosphate ( ddGTP ) 68726-28-3
D 020 2'- Deoxyguanosine- 3', 5'- cyclic monophosphate ( 2'-dcGMP ) 93919-42-7
D 021 7- Deazaadenosine- 3', 5'- cyclic monophosphate ( 7-CH-cAMP ) 16719-36-1
D 022 2'- Deoxy- 8- hydroxyguanosine ( 8-OH-dGuo ) 88847-89-6
D 025 2', 3'- Dideoxyguanosine- 5'- O- (1- thiotriphosphate) ( ddGTP-α-S ) 154771-50-3
D 026 2', 3'- Dideoxyadenosine- 5'- O- (1- thiotriphosphate) ( ddATP-α-S ) 154902-26-8
D 027 2', 3'- Dideoxycytidine- 5'- O- (1- thiotriphosphate) ( ddCTP-α-S ) 154771-49-0
D 028 2', 3'- Dideoxyuridine- 5'- O- (1- thiotriphosphate) ( ddUTP-α-S ) 1053668-88-4
D 029 3'- Deoxythymidine- 5'- O- (1- thiotriphosphate) ( dTTP-α-S ) / 2', 3'- Dideoxythymidine- 5'- O- (1- thiotriphosphate) ( ddTTP-α-S ) 154771-48-9
D 030 2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dGTP-α-S ) 80902-29-0
D 031 2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dGTP-α-S ) 80902-28-9
D 032 7- Deazaadenosine- 5'- O- monophosphate ( 7-CH-5'-AMP / 5'-TuMP ), sodium salt 16719-46-3
D 033 7- Deaza- 2'- deoxyadenosine- 5'- O- triphosphate ( 7-CH-dATP ) 67460-15-5
D 037 2', 3'- Dideoxycytidine- 5'- O- triphosphate ( ddCTP ) 132619-66-0
D 038 3'- Deoxythymidine- 5'- O- triphosphate ( dTTP ) / 2', 3'- Dideoxythymidine- 5'- O- triphosphate ( ddTTP ) 128524-26-5
D 039 2', 3'- Dideoxyguanosine ( ddG ) 085326-06-3
D 040 3'- Deoxythymidine / 2', 3'- Dideoxythymidine ( ddT ) 3416-05-5
D 041 3'- Deoxyguanosine ( 3'-dG ) 3608-58-0
D 042 (7- Diethylaminocoumarin- 4- yl)methyladenosine- 3', 5'- cyclic monophosphate ( DEACM-caged cAMP ) 339291-37-1
D 043 (7- Diethylaminocoumarin- 4- yl)methylguanosine- 3', 5'- cyclic monophosphate ( DEACM-caged cGMP ) 339291-42-8
D 044 (7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoadenosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cAMP ) none
D 045 (7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cGMP ) none
D 046 2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dCTP-α-S ) 80951-76-4
D 047 2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dCTP-α-S ) 80951-75-3
D 048 2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dUTP-α-S ) 876068-86-9
D 049 2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dUTP-α-S ) 876068-87-0
D 050 2'- Deoxy- 8- hydroxyadenosine ( 8-OH-dAdo ) 62471-63-0
D 051 PKG inhibitor peptide DT-2 pending
D 052 PKG inhibitor peptide DT-3 pending
D 054 P1, P2- Di- (adenosine- 5')- diphosphate ( Ap2A / AppA ) 85065-24-3
D 055 P1, P5- Di- (adenosine- 5')- pentaphosphate ( Ap5A / ApppppA ) 4097-04-5
D 056 2'- Deoxyguanosine- 5'- O- monophosphorothioate ( 5'-dGMPS ) 87358-26-7
D 057 2'- Deoxyuridine- 5'- O- monophosphorothioate ( 5'-dUMPS ) 205379-91-5
D 058 7- Deaza- 2'- deoxyadenosine- 5'- O- monophosphate ( 7-CH-5'-dAMP / 5'-dTuMP ) 103078-56-4
D 059 2'- Deoxycytidine- 5'- O- monophosphorothioate ( 5'-dCMPS ) 64145-27-3
D 060 2'- Deoxyinosine- 5'- O- monophosphorothioate ( 5'-dIMPS ) 771477-45-3
D 061 7- Deaza- 2'- deoxyadenosine- 5'- O- diphosphate ( 7-CH-dADP / 5'-dTuDP ) 187478-96-2
D 062 2'- Deoxyinosine 890-38-0
D 063 2, 6- Dichloro- 2', 3', 5'- triacetylpurine riboside 3056-18-6
D 064 2, 6- Dichloropurine riboside 13276-52-3
D 065 2'- Deoxyguanosine 961-07-9
D 069 4, 6- Dinitrobenzimidazole riboside- 3', 5'- cyclic monophosphate (4,6-DN-cBIMP) pending
D 073 2'- Deoxy- 2'- fluoroadenosine- 3', 5'- cyclic monophosphate ( 2'-F-dcAMP ) 81356-81-2
D 074 2'- Deoxy- 2'- fluoroadenosine- 5'- O- triphosphate ( 2'-F-ATP ) 73449-07-7
D 075 N4, 2'- O- Dibutyrylcytidine- 3', 5'- cyclic monophosphate ( DB-cCMP ) 64649-87-2
D 076 3', 5'- Diamino- 3', 5'- dideoxyadenosine ( 3',5'-DA-ddA ) 67313-23-9
D 077 2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- monophosphate ( ε-5'-dAMP ) 60508-81-8
D 078 2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- triphosphate ( ε-dATP ) 81004-54-8
D 079 2'- Deoxy- 2'- fluoroadenosine ( 2'-F-dAdo ) 64183-27-3
D 080 2'- Deoxy- 1, N6- ethenoadenosine ( ε-dAdo ) 68498-25-9
D 081 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-dAMP ) pending
D 082 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-dGMP ) pending
D 083 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-dADP ) 91828-83-0
D 084 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-dGDP ) 127383-33-9
D 085 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-dATP ) 128113-53-1
D 086 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-dGTP ) 124615-99-2
D 087 8- (2- [ DY-547]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-cGMP / 8-DY547-cGMP ) pending
D 089 8- (2- [ DY-547]- aminoethylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-2'-O-Me-cAMP ) pending
D 090 8- (2- [ DY-647]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-647]-AET-cGMP ) pending
D 091 7- Deazaadenosine- 5'- O- diphosphate ( 7-CH-ADP / 5'-TuDP ) 21080-53-5
D 092 2'- Deoxyadenosine- 3', 5'- O- bisphosphate ( pdAp ) 16174-58-6
D 093 2'- Deoxycytidine- 3', 5'- O- bisphosphate ( pdCp ) 4682-43-3
D 094 2'- Deoxyguanosine- 3', 5'- O- bisphosphate ( pdGp ) 16174-59-7
D 096 7- Deazaadenosine- 5'- O- triphosphate ( 7-CH-ATP ) 10058-66-9
D 099 7- Deazaguanosine- 3', 5'- cyclic monophosphate ( 7-CH-cGMP ) 81611-03-2
D 101 2'-, 2''- O- ( Di- N'- methylanthraniloyl)- cyclic diguanosine monophosphate ( Di-MANT-c-diGMP ) pending
D 104 2'- Deoxy- N6- (2- phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-dATP ) 1239610-11-7
D 108 8- Dimethylamino- cyclic inosine diphosphate ribose ( 8-DMA-N1-cIDPR ) pending
D 109 8- (2- [DY-547]- aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-cAMP / fcAMP ) pending
D 110 PKG inhibitor peptide (D)-DT-2 pending
D 111 2'-, 2''- O- ( Di- 6- [biotinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2',2''-Di-[Biotin]-AHC-c-diGMP ) pending
D 112 2'- , 2''- O- ( Di- [6- aminohexylcarbamoyl])- cyclic diguanosine monophosphate ( 2',2''-Di-AHC-c-diGMP ) pending
D 113 8-, 8'- Dibromo- cyclic diguanosine monophosphate ( 8,8'-Di-Br-c-diGMP ) 1357147-61-5
D 114 6- (?- D- 2- Deoxyribofuranosyl)- 3, 4- dihydro- 8H- pyrimido- [4, 5- c]- [1, 2]- oxazin- 7- one- 5'- O- triphosphate ( 2'-Deoxy-P-nucleoside-5'-O-triphosphate / dPTP ) 173964-83-5
D 115 P1, P4- Di- (adenosine- 5')- tetraphosphate ( Ap4A / AppppA ) 5542-28-9
D 116 2'- O- (6- [ DY-547]- aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-[DY-547]-AHC-c-diGMP ) pending
D 117 P1, P3- Di- (adenosine- 5')- triphosphate ( Ap3A / ApppA ) 5959-90-0
D 119 P1, P4- Di- (guanosine- 5')- tetraphosphate ( Gp4G / GppppG ) 4130-19-2
D 121 2'- , 2''- O- ( Di- [6- aminohexylcarbamoyl])- cyclic diadenosine monophosphate ( 2',2''-Di-AHC-c-diAMP ) pending
D 122 2', 2''- O- ( Di- (6- [biotinyl]aminohexylcarbamoyl))- cyclic diadenosine monophosphate ( 2',2''-Di-[Biotin]-AHC-c-diAMP ) pending
D 127 P1, P2- Di- (cytidine- 5')- diphosphate ( Cp2C / CppC ) 29789-88-6
D 128 P1, P2- Di- (uridine- 5')- diphosphate ( Up2U / UppU ) 26184-65-6
D 129 P1, P4- Di- (uridine- 5')- tetraphosphate ( Up4U / UppppU ) 59985-21-6
D 132 2'- , 2''- Dideoxy- 2'-, 2''- difluoro- cyclic diadenosine monophosphate ( 2',2''-Di-F-c-didAMP ) pending
D 135 2'- O- (6- [DY505-05]- aminohexylcarbamoyl))guanosine-3',5'-cyclic monophosphate ( 2'-[DY-505-05]-AHC-cGMP ) pending
D 136 2'-, 2''- O- ( Di- methyl)- cyclic diguanosine monophosphate ( 2',2''-Di-O-Me-c-diGMP ) 849214-02-4
D 139 2'-, 2''- Dideoxy- cyclic diguanosine monophosphate ( 2',2''-Di-c-didGMP ) 60307-63-3
D 140 2'- , 2''- Dideoxy- cyclic diadenosine monophosphate ( 2',2''-Di-c-didAMP ) 79192-34-0
D 143 2'- Deoxy- 2''- O- methyl- cyclic diadenosine monophosphate ( c-di-2'-d-2''-O-Me-AMP / c-(2'-dAp-2'-O-Me-Ap) ) pending
D 144 2'- Deoxy- cyclic diadenosine monophosphate ( c-di-2'-dAMP / c-(2'-dApAp) ) pending
D 145 2'- Deoxy- cyclic diguanosine monophosphate ( c-di-2'-dGMP / c-(2'-dGpGp) / c-dG-GMP ) 132182-18-4
D 148 ?- ara- 2'- Deoxy- 2'- fluoro- nicotinamide adenine dinucleotide ( ara-2'-F-NAD+ ) 133575-27-6
D 154 2'- , 2''- O- ( Di- methyl)- cyclic diadenosine monophosphate ( 2',2''-Di-O-Me-c-diAMP ) 1427269-46-2
D 159 2'-, 2''- O- ( Di- N'- methylanthraniloyl)- cyclic diadenosine monophosphate ( Di-MANT-c-diAMP ) pending
D 160 P1, P5- Di- (inosine- 5')- pentaphosphate ( Ip5I / IpppppI ) 1294478-76-4
E 001 1, N6- Ethenoadenosine- 3', 5'- cyclic monophosphate ( ε-cAMP ) 103213-51-0
E 004 1, N6- Ethenoadenosine- 5'- O- triphosphate ( ε-ATP ) 60777-99-3
E 005 1, N6- Ethenoadenosine- 5'- O- monophosphate ( ε-5'-AMP ) 103213-41-8
E 007 1, N6- Ethenoadenosine- 5'- O- diphosphate ( ε-ADP ) 103213-52-1
E 010 Ethanolamine; immobilized on agarose gel ( EtOH-NH-Agarose ) pending
E 011 1, N6- Ethenoadenosine ( ε-Ado ) 39007-51-7
E 012 1, N6- Ethenoadenine ( ε-Ade ) 13875-63-3
E 013 1, N6- Ethenoadenosine- 5'- O- diphosphoribose ( ε-ADPR / ε-ADP-ribose ) 69699-76-9
E 016 1, N6- Ethenoadenosine- 5'- O- diphosphoribose phosphate ( ε-ADPRP ) 98088-66-5
F 001 8- (2- [ Fluoresceinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[Fluo]-cGMP / 8-[Fluo]-AET-cGMP ) pending
F 002 8- (2- [ Fluoresceinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[Fluo]-cAMP / 8-[Fluo]-AET-cAMP ) 293296-57-8
F 003 2'- (6- [ Fluoresceinyl]aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cAMP / FAM-cAMP ) pending
F 004 2'- (6- [ Fluoresceinyl]aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cGMP / FAM-cGMP ) pending
F 006 N6- Furfuryladenosine- 5'- O- diphosphate ( 6-Fu-ADP ) pending
F 007 N6- Furfuryladenosine- 5'- O- triphosphate ( 6-Fu-ATP ) / Kinetin triphosphate ( KTP ) 1450894-16-2
F 008 N6- Furfuryladenosine- 5'- O- (3- thiotriphosphate) ( 6-Fu-ATP-γ-S ) 1400539-83-4
F 009 2'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-Fluo-AHC-c-diGMP ) pending
F 010 2'- / 3'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)adenosine- 5'- O- monophosphate ( 2'- / 3'-Fluo-AHC-5'-AMP ) pending
F 011 2'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-Fluo-AHC-c-diAMP ) pending
F 012 8- (6- [ Fluoresceinyl]aminohexylthio)- ?- phenyl- 1, N2- ethenoguanosine- 3', 5'- cyclic monophosphate ( 8-[Fluo]-AHT-PET-cGMP ) [pending]
G 001 Guanosine- 3', 5'- cyclic monophosphate ( cGMP ) 40732-48-7
G 002 Guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cGMP-AM ) 164007-71-0
G 012 Guanosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-GDP-α-S ) 71481-44-2
G 013 Guanosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-GDP-α-S ) 71481-45-3
G 014 Guanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-GTP-α-S ) 81570-50-5
G 015 Guanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-GTP-α-S ) 81570-51-6
G 016 Guanosine- 3', 5'- cyclic monophosphorothioate, Rp-isomer ( Rp-cGMPS ) 86562-09-6
G 017 Guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cGMPS ) 86562-10-9
G 018 Guanosine- 5'- O- monophosphorothioate ( 5'-GMPS ) 76310-16-2
G 019 Guanosine- 5'- O- (3- thiotriphosphate) ( GTP-γ-S ) 37589-80-3
G 021 Guanosine- 3'- O- monophosphate ( 3'-GMP ) 6027-83-4
G 022 Guanosine- 2'- O- monophosphate ( 2'-GMP ) 130-50-7
G 023 Guanosine- 5'- O- (2- thiodiphosphate) ( GDP-β-S ) 71376-97-1
G 024 Guanosine- 5'- O- (α, β- methylene)diphosphate ( GMP-CP ) 32381-15-0
G 025 Guanosine- 2', 3'- cyclic monophosphate ( 2',3'-cGMP ) 15718-49-7
G 026 Guanosine- 5'- O- triphosphoro- γ- 1- (5- sulfonic acid)naphthylamidate ( GTP-γ-AmNS ) 76724-84-0
G 027 P1- (5'- Guanosyl)- P4- (5'- uridyl)- tetraphosphate ( Gp4U / Up4G ) 79695-25-3
G 028 Guanosine- 5'- O- diphosphate, immobilized on a polymeric matrix ( GDP-Gel / GDP-Agarose ) pending
H 001 8- Hydroxyguanosine ( 8-OH-Guo ) 3868-31-3
H 002 8- Hydroxyguanine ( 8-OH-Gua ) 5614-64-2
H 003 8- Hydroxyadenosine- 3', 5'- cyclic monophosphate ( 8-OH-cAMP ) 31356-95-3
H 004 8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-OH-cAMPS ) 475084-30-1
H 005 8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-OH-cAMPS ) 749843-87-6
H 006 8- Hexylaminoadenosine- 3', 5'- cyclic monophosphate ( 8-HA-cAMP ) 59212-44-1
H 007 8- Hydroxyadenine ( 8-OH-Ade ) 21149-26-8
H 010 8- (4- Hydroxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pHPT-2'-O-Me-cAMP ) 612513-15-2
H 011 8- Hydroxyadenosine ( 8-OH-Ado ) 29851-57-8
H 012 6- Hexylthioguanosine- 3', 5'- cyclic monophosphate ( 6-HT-cGMP ) pending
H 013 8- Hydroxy- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-OH-2'-O-Me-cAMP ) pending
H 016 8- Hydroxyguanosine- 3', 5'- cyclic monophosphate ( 8-OH-cGMP ) 21082-28-0
H 017 2- Hydroxyadenine ( 2-OH-Ade ) 3373-53-3
I 001 Inosine- 3', 5'- cyclic monophosphate ( cIMP ) 41092-64-2
I 004 5- Iodotubercidin ( 5-I-Tu ) / 7- Deaza- 7- iodoadenosine 24386-93-4
I 005 2', 3'- Isopropylideneinosine 2140-11-6
I 006 Inosine 58-63-9
I 007 2', 3'- Isopropylideneguanosine ( 2',3'-Ipr-Guo ) 362-76-5
K 001 Ko-Libri Library of Nucleosides and Nucleobases none
K 002 Ko-Libri Library of Cyclic Nucleotides none
M 001 8- Methylaminoadenosine- 3', 5' cyclic monophosphate ( 8-MA-cAMP ) 33823-18-6
M 003 N6- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 6-MB-cAMP ) 70253-67-7
M 004 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-O-MB-cAMPS ) 152218-23-0
M 005 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-O-MB-cAMPS ) 152218-23-0
M 006 2'- O- Monobutyrylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-MB-cGMP ) 58329-72-9
M 007 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 2'-O-MB-cAMP ) 55443-13-5
M 008 2'- O- (N- Methylanthraniloyl)adenosine- 3', 5'- cyclic monophosphate ( MANT-cAMP ) 83707-14-6
M 009 2'- O- (N- Methylanthraniloyl)guanosine- 3', 5'- cyclic monophosphate ( MANT-cGMP ) 83707-15-7
M 010 N2- Methylguanosine- 3', 5'- cyclic monophosphate ( 2-Me-cGMP) 205368-54-3
M 011 2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cAMP ) 36940-87-1
M 012 N6- Mono- tert. butylcarbamoyladenosine- 3', 5'- cyclic monophosphate ( 6-MBC-cAMP ) 84433-46-5
M 015 2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cGMP ) 39118-26-8
M 016 8- (4- [N- Methylanthraniloyl]aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-MABA-cAMP ) 909782-76-9
M 017 N6- (6- [N- Methylanthraniloyl]hexylamino)adenosine-3', 5'- cyclic monophosphate ( 6-MAH-cAMP ) 723313-27-7
M 020 2- Methylthioadenosine- 5'- O- diphosphate ( 2-MeS-ADP / 2-MeSADP ) 34983-48-7
M 021 2- Methylthioadenosine- 5'- O- triphosphate ( 2-MeS-ATP / 2-MeSATP ) 43170-89-4
M 022 2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cAMP ) 60448-20-6
M 023 2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cGMP ) 104872-93-7
M 024 N6- (3- Methylbenzyl)adenosine- 5'- O- diphosphate ( 6-(3-MeBn)-ADP ) 681175-78-0
M 025 N6- (3- Methylbenzyl)adenosine- 5'- O- triphosphate ( 6-(3-MeBn)-ATP ) 215321-95-2
M 026 N6- (1- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-(1-MeBu)-ADP ) pending
M 027 N6- (1- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-(1-MeBu)-ATP ) 252889-13-7
M 028 N6- (2- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-(2-MeBu)-ADP ) 681175-77-9
M 029 N6- (2- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-(2-MeBu)-ATP ) 252889-14-8
M 030 2'- / 3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-ATP ) 151481-86-6
M 031 2- Methylthioadenosine- 5'- O- monophosphate ( 2-MeS-5'-AMP / 2-MeSAMP ) 22140-20-1
M 032 2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-GTP ) 148821-03-8